Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert B Jenkins

Showing results (111-120 of 269) with videos related to

Pageof 27
Sort By:
Genes, Chromosomes & Cancer|June 23, 2009
Characterization and gene expression profiling in glioma cell lines with deletion of chromosome 19 before and after microcell-mediated restoration of normal human chromosome 19Kristen L Drucker, Gaspar J Kitange, Thomas M Kollmeyer, et al.
Oncotarget|April 15, 2014
The IncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancerJohn R Prensner, Anirban Sahu, Matthew K Iyer, et al.
Neuro-Oncology|June 25, 2024
Genome-wide polygenic risk scores predict risk of glioma and molecular subtypesTaishi Nakase, Geno A Guerra, Quinn T Ostrom, et al.
The Prostate|August 4, 2019
A four-gene transcript score to predict metastatic-lethal progression in men treated for localized prostate cancer: Development and validation studiesAnqi Cheng, Shanshan Zhao, Liesel M FitzGerald, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 24, 2008
Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesisBora Gurel, Tsuyoshi Iwata, Cheryl M Koh, et al.
Neuro-Oncology|November 1, 2020
Functional analysis of low-grade glioma genetic variants predicts key target genes and transcription factorsMohith Manjunath, Jialu Yan, Yeoan Youn, et al.
Journal of the National Cancer Institute|December 6, 2011
Predictability of adjuvant trastuzumab benefit in N9831 patients using the ASCO/CAP HER2-positivity criteriaEdith A Perez, Amylou C Dueck, Ann E McCullough, et al.
The CRISPR Journal|April 18, 2023
Clonally Selected Lines After CRISPR-Cas Editing Are Not IsogenicArijit Panda, Milovan Suvakov, Jessica Mariani, et al.
Journal of Neuropathology and Experimental Neurology|November 20, 2008
Gene expression profiling of NF-1-associated and sporadic pilocytic astrocytoma identifies aldehyde dehydrogenase 1 family member L1 (ALDH1L1) as an underexpressed candidate biomarker in aggressive subtypesFausto J Rodriguez, Caterina Giannini, Yan W Asmann, et al.
Neuro-Oncology Practice|March 5, 2016
Understanding inherited genetic risk of adult glioma - a reviewTerri Rice, Daniel H Lachance, Annette M Molinaro, et al.
Pageof 27

Showing results (111-120 of 269) with videos related to

Sort By:
Pageof 27
Genes, Chromosomes & Cancer|June 23, 2009
Characterization and gene expression profiling in glioma cell lines with deletion of chromosome 19 before and after microcell-mediated restoration of normal human chromosome 19Kristen L Drucker, Gaspar J Kitange, Thomas M Kollmeyer, et al.
Oncotarget|April 15, 2014
The IncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancerJohn R Prensner, Anirban Sahu, Matthew K Iyer, et al.
Neuro-Oncology|June 25, 2024
Genome-wide polygenic risk scores predict risk of glioma and molecular subtypesTaishi Nakase, Geno A Guerra, Quinn T Ostrom, et al.
The Prostate|August 4, 2019
A four-gene transcript score to predict metastatic-lethal progression in men treated for localized prostate cancer: Development and validation studiesAnqi Cheng, Shanshan Zhao, Liesel M FitzGerald, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 24, 2008
Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesisBora Gurel, Tsuyoshi Iwata, Cheryl M Koh, et al.
Neuro-Oncology|November 1, 2020
Functional analysis of low-grade glioma genetic variants predicts key target genes and transcription factorsMohith Manjunath, Jialu Yan, Yeoan Youn, et al.
Journal of the National Cancer Institute|December 6, 2011
Predictability of adjuvant trastuzumab benefit in N9831 patients using the ASCO/CAP HER2-positivity criteriaEdith A Perez, Amylou C Dueck, Ann E McCullough, et al.
The CRISPR Journal|April 18, 2023
Clonally Selected Lines After CRISPR-Cas Editing Are Not IsogenicArijit Panda, Milovan Suvakov, Jessica Mariani, et al.
Journal of Neuropathology and Experimental Neurology|November 20, 2008
Gene expression profiling of NF-1-associated and sporadic pilocytic astrocytoma identifies aldehyde dehydrogenase 1 family member L1 (ALDH1L1) as an underexpressed candidate biomarker in aggressive subtypesFausto J Rodriguez, Caterina Giannini, Yan W Asmann, et al.
Neuro-Oncology Practice|March 5, 2016
Understanding inherited genetic risk of adult glioma - a reviewTerri Rice, Daniel H Lachance, Annette M Molinaro, et al.
Pageof 27